VivoSim Labs, INC. (VIVS) stock
VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$0.12−0.00 (-0.08%)
Close on Nov 18, 2026Market cap $383.32KP/E –Yield –
VivoSim Labs pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for VivoSim Labs
VivoSim Labs has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?